全球伴侶動物保健市場規模、佔有率、趨勢和成長分析報告（2026-2034）

全球伴侶動物藥品市場預計將從2025年的288.1億美元成長至2034年的756.3億美元，2026年至2034年的複合年成長率（CAGR）為11.32%。寵物飼養量的增加以及人們對動物健康和福祉意識的提高，正推動該市場實現顯著成長。隨著越來越多的家庭將寵物視為家庭成員，對獸醫服務和產品的需求也隨之激增。寵物飼主越來越重視預防性護理，從而擴大了疫苗、診斷和治療產品的市場。在寵物飼養率高且消費者願意為寵物健康和福祉投資的地區，這一趨勢尤其明顯。隨著市場的不斷發展，獸醫學和技術的創新有望提升伴侶動物的醫療服務品質。

此外，寵物「擬人化」的趨勢正對伴侶動物醫療保健市場產生重大影響。隨著寵物日益被視為家庭成員，飼主也開始尋求與人類同等的高品質醫療保健服務。這種轉變推動了對先進療法的需求，包括針對伴侶動物獨特需求的專科手術、牙科護理和營養補充劑。此外，獸醫遠端醫療的興起也讓飼主更容易獲得專家建議和服務，進一步擴大了市場。隨著人們對寵物健康和福祉的日益關注，伴侶動物藥品市場預計將保持活力，並持續滿足飼主不斷變化的需求。

此外，研發領域的進步也正在重振伴侶動物藥品市場。新藥、生物製藥和診斷工具的出現，提高了診斷和治療各種寵物疾病的能力。隨著獸醫專業人員獲得更有效的治療方案，伴侶動物的整體護理品質有望得到提升。此外，獸醫專業人員與寵物產品製造商之間日益密切的合作，正在推動市場創新，並促成新型有效解決方案的開發。隨著伴侶動物藥品市場的不斷發展，在對高品質獸醫護理需求不斷成長的推動下，預計將保持持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球伴侶動物保健市場：依適應症分類

• 市場分析、洞察與預測
• 感染疾病
• 皮膚病
• 疼痛
• 整形外科疾病
• 行為障礙
• 其他（牙科、心臟、懷孕、癌症）

第5章：全球伴侶動物保健市場：依給藥途徑分類

• 市場分析、洞察與預測
• 口服
• 注射藥物
• 外用

第6章 全球伴侶動物保健市場：依動物類型分類

• 市場分析、洞察與預測
• 狗
• 貓
• 馬
• 其他伴侶動物

第7章 全球伴侶動物保健市場：依通路分類

• 市場分析、洞察與預測
• 動物醫院
• 動物診所
• 零售藥房

第8章 全球伴侶動物保健市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Ceva Sante Animale
  • Virbac
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Neogen Corporation
  • Orion Group
  • Norbrook Holdings
  • Chanelle Pharma
  • HIPRA
  • Kyoritsu Seiyaku
  • Biogenesis Bago

The global companion animal medicine market size is expected to reach USD 75.63 Billion in 2034 from USD 28.81 Billion in 2025, growing at a CAGR of 11.32 during 2026-2034.The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.

Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.

Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Indication

• Infectious Diseases
• Dermatologic Diseases (Skin Diseases)
• Pain
• Orthopedic Diseases
• Behavioral Disorders
• Others (Dental, Cardio, Pregnancy, Cancer)

By Route of Administration

• Oral
• Injectable
• Topical

By Animal Type

• Dogs
• Cats
• Horses
• Other Companion Animals

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Orion Group, Norbrook Holdings, Chanelle Pharma, HIPRA, Kyoritsu Seiyaku, Biogenesis Bago

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dermatologic Diseases (Skin Diseases) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Orthopedic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Behavioral Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others (Dental, Cardio, Pregnancy, Cancer) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Indication
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Animal Type
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Indication
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Animal Type
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Indication
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Animal Type
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Indication
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Animal Type
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Indication
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Animal Type
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL MEDICINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Merck Animal Health
  • 10.2.3 Boehringer Ingelheim Animal Health
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Ceva Sante Animale
  • 10.2.6 Virbac
  • 10.2.7 Dechra Pharmaceuticals
  • 10.2.8 Vetoquinol
  • 10.2.9 Neogen Corporation
  • 10.2.10 Orion Group
  • 10.2.11 Norbrook Holdings
  • 10.2.12 Chanelle Pharma
  • 10.2.13 HIPRA
  • 10.2.14 Kyoritsu Seiyaku
  • 10.2.15 Biogenesis Bago